Latest Breaking News On - Grand pharmaceutical - Page 3 : comparemela.com

Glenmark receives marketing approval for Ryaltris®, an innovative combination nasal spray, in 13 countries across the EU and UK

Glenmark receives marketing approval for Ryaltris®, an innovative combination nasal spray, in 13 countries across the EU and UK
theprint.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theprint.in Daily Mail and Mail on Sunday newspapers.

Malaysia
Australia
Philippines
United-kingdom
Uzbekistan
Brazil
China
Czech-republic
Yuhan
Anhui
South-africa
Canada

Glenmark gets marketing approval for Ryaltris in 13 EU, UK countries

Glenmark gets marketing approval for Ryaltris in 13 EU, UK countries
dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.

Malaysia
Australia
Philippines
United-kingdom
Uzbekistan
Brazil
China
Czech-republic
Yuhan
Anhui
South-africa
Canada

$ 209.08 Mn Growth Opportunity in Embolization Coil Market 2021-2025 | Analysis of 25+ Companies

$ 209.08 Mn Growth Opportunity in Embolization Coil Market 2021-2025 | Analysis of 25+ Companies
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United-states
Hungary
Hong-kong
United-kingdom
China
Boston
Massachusetts
Indonesia
Ireland
France
Turkey
Greece

China Pharmaceutical Market and Healthcare Industry Forecast and Analysis Report 2021-2025

China Pharmaceutical Market and Healthcare Industry Forecast and Analysis Report 2021-2025
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

China
Shanghai
Yiling
Jiangxi
Nanjing
Jiangsu
Chinese
Eli-lilly
Laura-wood
Glaxosmithkline
Jiangsu-simcere-pharmaceutical-co
Sino-biopharmaceutical

Glenmark's Ryaltris® nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age

Glenmark s Ryaltris® nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age News provided by Share this article Share this article The launch will ensure much-needed access to a novel fixed-dose combination nasal spray for this chronic condition This marks Glenmark s first innovative product approval in the European Union MUMBAI, India, April 26, 2021 /PRNewswire/ Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, is concluding the final, national phase of its marketing approval application process to enable launch of its innovative nasal spray in 17 countries in the European Union. Ryaltris

Australia
United-kingdom
Brazil
China
Czech-republic
Austria
Russia
Ukraine
Mumbai
Maharashtra
India
Netherlands